Happy Belly Food Group Inc. (VGANF)

[Renee]

VGANF: effective Sept. 1,2022 Plant and Co Brands Ltd. will change to Happy Belly Food Group Inc.:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Renee]

EURPF changed to VGANF:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Renee]

EURPF: effective Dec. 4,2020 Eurolife Brands Inc. will change to Plant and Co Brands Ltd.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Renee]

EURPF effective July 2,2020 a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Renee]

CANVF changed to EURPF

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[BowDoga]

Market makers dream

[greenwillow]

Yeah, after a few decent days the bids disappeared.

There were a couple of people throwing in 0011 /0027 bids yesterday.

Enjoy the rest of the vacation!

[PotterBanker]

been on vacation... wtf?

[greenwillow]

Damn that's a big spread!

[Renee]

CANVF: effective Aug. 14,2019 Cannvas MedTech Inc. will change to Eurolife Brands Inc.:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-appoints-ryerson-university-s-brad-poulos-to-its-education-advisory-board-887571516.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-signs-definitive-contract-with-liberty-leaf-as-exclusive-cannabis-education-provider-871951516.html

[PotterBanker]

yes, well it will have to start trading more than 1000 shares a day first. lol

[greenwillow]

One of these days, Cannvas will gain some pps traction.

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-signs-definitive-contract-with-mm-patient-relief-as-exclusive-cannabis-education-provider-861124853.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-enters-european-markets-following-successful-entry-into-u-s-cannabis-market-894077192.html

[greenwillow]

haha...

One of these days!

[PotterBanker]

I don't know about quietly...

they blow the news horn at least twice a week lol

[greenwillow]

Quietly advancing.

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-continues-to-increase-digital-assets-to-drive-site-traffic-user-growth-805441627.html

[greenwillow]

Certainly moving in the right direction.

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-refreshes-brand-positioning-and-outlines-revenue-generating-products-and-services-808023418.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-launches-pet-focused-cannabis-education-platform-in-the-united-states-870315796.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-secures-revenue-agreement-with-medical-marihuana-patient-relief-891290452.html

https://www.newswire.ca/news-releases/cannvas-engages-catapult-growth-partners-to-explore-transactions-within-global-cannabis-sector-808907130.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-secures-revenue-agreement-with-medical-marihuana-patient-relief-891290452.html

[PotterBanker]

Cannvas Signs Exclusive Cannabis Education and Revenue Sharing Agreement With Luxury Automobile Club

https://www.newswire.ca/en/releases/archive/April2019/25/c5568.html

Quebec-Based Le Qlub First Member of Cannvas Drive Responsible Program

TORONTO, April 25, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has signed an agreement with Le Qlub, a premier Quebec-based exotic car rental company, to be its exclusive provider of cannabis education with the luxury automobile club as the first member of the Cannvas Drive Responsible Program. The agreement also supports revenue-sharing between the two organizations with Le Qlub offering exclusive discounts and promotions to Cannvas users.

"We are excited to partner with Le Qlub and welcome them to our Cannvas Drive Responsible Program, an ongoing awareness campaign we hope to expand across Canada with the support of strategic partners to promote education about the dangers of driving under the influence of cannabis," said Steve Loutsou, Chief Operating Officer, Cannvas MedTech. "Le Qlub and its clients win by learning more about cannabis, its potential benefits for a range of health concerns and the importance of safe and responsible driving for potential cannabis users, while Cannvas gains additional users educating themselves on all aspects of cannabis and sharing valuable research and consumption information - it's a win-win scenario for all parties."

Cannvas will provide printed educational material to be placed prominently in each vehicle in Le Qlub's fleet, including mirror hangers, window decals and glovebox flyers. Each piece will have information on safe cannabis consumption as it relates to driving, using material created for the Cannvas.Me digital cannabis education resource by the platform's independent Medical, Educational and Cannabis Sciences Advisory Boards.

The agreement also sets in place a lead-generating aspect wherein Le Qlub will offer exclusive discounts and promotions to Cannvas users, encouraging residents of and visitors to Quebec to complement their trip with the enjoyment of a reasonably-priced rental of a luxury automobile of their choice.

The agreement brings Le Qlub on board as the inaugural member of the Cannvas Drive Responsible Program, an initiative aimed at increasing awareness of the risks associated with driving under the influence of cannabis. According to a Statistics Canada report in the second quarter of 2018, "one in seven cannabis users reported driving at least once within two hours of using cannabis in the past three months, and one in 20 Canadians reported being a passenger in a vehicle driven by someone who had consumed cannabis in the previous two hours."

About Le Qlub
Le Qlub™ is a premier exotic car rental company for individuals in search of an exotic car rental in Montreal. Le Qlub™ provides a pristine luxury experience for new and experienced clientele. For more information please visit LeQlub.ca.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

[PotterBanker]

"Exclusive Partnership"

[greenwillow]

Another interesting partnership!

[PotterBanker]

Cannvas Selected to Join The International Cannabis Alliance as Exclusive Provider of Cannabis Education

https://www.newswire.ca/news-releases/cannvas-selected-to-join-the-international-cannabis-alliance-as-exclusive-provider-of-cannabis-education-860650808.html

Industry Leaders Join Forces to Improve Accessibility to Unbiased and Evidence-Based Cannabis Education

TORONTO, April 24, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has joined the International Cannabis Alliance ("InterCannAlliance"), bringing advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe, as its exclusive provider of cannabis education. The InterCannAlliance is an international project led by New Frontier Data, an independent, technology-driven analytics company specializing in the cannabis industry.

"We are proud to join the International Cannabis Alliance in its efforts to educate future leaders in the global cannabis industry and develop a framework for delivering unbiased and evidence-based consumer education around cannabis as laid out in its nine founding pillars," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "This opportunity extends the global reach of the Cannvas brand, opens doors to exciting new ventures and projects with partners spanning the globe, and strengthens our market position as a leader in cannabis education in Canada and across the world."

Cannvas will work with the InterCannAlliance to deliver physician-backed and evidence-based cannabis education powered by its digital cannabis learning resource Cannvas.Me. With a focus on audiences in new and evolving legal cannabis markets, InterCannAlliance will review all original content on Cannvas.Me and work with the Cannvas team to identify appropriate learning modules to adapt and make available to their community. The partnership also opens the door to opportunities for Cannvas to explore projects with New Frontier Data as part of its cannabis analytics platform Cannvas Data, as the two organizations share the same mission of elevating the discussion around the legal cannabis industry globally by providing unbiased vetted information and educating stakeholders to make informed decisions.

The International Cannabis Alliance was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. Its mission is to educate and inform future market and thought leaders interested in the cannabis industry, fostering responsible, transparent and effective market practices learned across more mature North American cannabis sectors.

Uniting recognized leaders from industry segments considered to be critical building blocks for any cannabis market, InterCannAlliance seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations. The InterCannAlliance conducts one-day, invitation-only regional symposia to foster collaboration among governments, non-governmental organizations and commercial enterprises to educate stakeholders about opportunities, risks, and challenges in these markets.

About InterCannAlliance:
The International Cannabis Alliance (InterCannAlliance) was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. As established and emerging markets look to cannabis to reinvigorate their economies, healthcare and a range of industries, InterCannAlliance unites recognized leaders from industry segments considered to be critical building blocks for any cannabis market. The organization seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations and to help emerging markets capitalize on lessons learned elsewhere. The InterCannAlliance conducts invitation-only quarterly regional symposia to facilitate collaboration among governments, non-government organizations and large commercial enterprises to expedite access to and assessment of opportunities while accelerating growth. For more information, visit www.intercannalliance.com.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

For further information: [e-mail] or visit Cannvas.com
Related Links

https://cannvasmedtech.com

[PotterBanker]

Empower Announces Partnership With Cannvas MedTech to Advance Patient Education

https://www.newswire.ca/news-releases/empower-announces-partnership-with-cannvas-medtech-to-advance-patient-education-830832513.html

Empower Clinics Inc. is launching a pilot program with Cannvas MedTech to place educational kiosks in each of the Empower clinics to advance the education of patients, collection of data and analysis of physician recommended alternative CBD based therapies.

VANCOUVER, April 18, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented, diversified health and wellness company, is pleased to announce that it intends to partner with Cannvas MedTech Inc. ("Cannvas") (CSE: MTEC) (FRA: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, to create a pilot to launch a comprehensive education, data collection and analysis program starting with the installation of a network of standalone on-site Cannvas educational kiosks in the Empower network of medical clinics.

"This is an opportunity to bring unbiased cannabis education to a large population of patients looking for therapies to alleviate a number of ailments while also learning more about what behaviours may drive the decision to look at cannabis as an alternative or complementary treatment," said Shawn Moniz, Chief Executive Officer, Cannvas. "We are thrilled to partner with Empower Clinics to couple cannabis education with data analysis and better serve their patients while growing the Cannvas brand across the United States."

It is expected that Cannvas will place its Cannvas kiosks throughout Empower's network of clinics to provide accessible and unbiased cannabis education to Empower's patients, integrating geo-targeting capabilities to ensure relevant contextual information across the country. Cannvas will be a key data and analytics partner for Empower by providing meaningful insights on customer behaviours and industry trends and integrating mutually beneficial existing data partnerships.

"In recent weeks, the Company has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients' lives with products, technology and health systems", stated Steven McAuley, Empower CEO, "the addition of the Cannvas educational kiosks, a user friendly and highly interactive education platform, is a tremendous step forward to making our brand one of the go to sources for content for both patients and the medical community nationwide."

Every month Empower hosts informational sessions about alternative treatment options and the potential health benefits with doctors and staff available to answer questions. It is expected that Cannvas will play an active role in the review and implementation of new educational curriculum based on original content from Cannvas website, Cannvas.me.

The Company also plans to begin further pilot initiatives with Cannvas to provide content and educational links to Cannvas.me and Cannvas.health directly from the new Empower website www.empowerclinics.com and through the Empower tele-medicine portal.

ABOUT EMPOWER

Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.

ABOUT CANNVAS MEDTECH

Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

[PotterBanker]

Cannvas Secures Partnership with Data-Driven Cannabis-Focused California Real Estate Firm

https://www.newswire.ca/news-releases/cannvas-secures-partnership-with-data-driven-cannabis-focused-california-real-estate-firm-872495035.html

Cannvas Data Platform To Provide Key Consumer, Retail Insights to Buyers Through Rebranded Company

TORONTO, April 17, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce Cannvas has entered into a definitive partnership with California-based real estate brokerage Good Karma, an innovative two-year-old agency specializing in the California commercial market, to provide detailed analysis and insights into the California market through its Cannvas Data platform while also undertaking a contemporary rebrand of the company.

"Through the analysis of high-level cannabis consumer data, Cannvas is well-positioned to support hopeful cannabis retailers with key demographic information on their target audiences, ensuring optimal location selection to drive awareness and profit," said Steve Loutskou, Chief Operating Officer, Cannvas Medtech Inc. "With this partnership between Good Karma and Cannvas, we are poised to help cannabis retailers target ideal locations for their business using the million-plus data points we have collected on potential and active cannabis consumers across North America."

According to a recent Allen Matkins/UCLA Anderson Forecast California Commercial Real Estate Survey, overall retail sales in the U.S. have increased at a 5.3 percent annual rate while retail markets struggle in California due to the onset of e-commerce that has grown at a 10.7 percent rate. However, industrial real estate is trending upward in the golden state, dominated by warehousing and distribution centres. Among its plans, Cannvas hopes to work with Good Karma to identify key industrial sites to act as strategically-placed distribution hubs for cannabis retailers across the state.

Cannvas expects this partnership to facilitate conversations with California cannabis producers and retailers looking to leverage a growing and diversifying customer base increasingly turning to cannabis to curb unhealthy habits or replace/complement traditional pain medication. Through the use of demographic and firmographic data, Cannvas can identify desirable consumer behaviour traits in specific regions across the state, helping to drive decisions on where to open up shop and reach new and potential customers.

With a population of nearly 40 million, California is considered to be among the largest recreational and medical cannabis markets in the world, alongside Canada. In the late 1990s, it was the first U.S. state to legalize medical cannabis and recreational cannabis sales became legal in January 2018. That year, the New York Times reports California retail stores sold US $2.5 billion of cannabis, compared to $1.5 billion or lower in Colorado, Washington and Oregon. According to BDS Analytics, the golden state is projected to account for nearly $25 billion of cannabis sales by 2026.

Good Karma was founded in Silicon Valley in 2016 by Len Sterling. A native of California and certified medical professional, Mr. Sterling has a reputation for prudent management from decades of experience in recruitment, sales and management.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

[PotterBanker]

yes, but this is roll-out pr!

not a thing on the bid CSE. I'm hoping someone gets impatient.

[greenwillow]

These guys do more pr than namaste used to...lol

[PotterBanker]

Cannvas Partners with Leading U.S. Cannabis Kiosk Company, Seed Technology and Prepares Global Rollout

https://www.newswire.ca/news-releases/cannvas-partners-with-leading-u-s-cannabis-kiosk-company-seed-technology-and-prepares-global-rollout-886641785.html

Cannvas Acquires Exclusive Canadian Rights to Distribution of Co-Branded Kiosks

TORONTO, April 11, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce a definitive partnership with Seed Technology, a California, USA based interactive customer-focused cannabis education platform, granting Cannvas exclusive Canadian rights to distribute co-branded kiosks and related technology to medical clinics and dispensaries across Canada.

"Seed Technology has established itself as a premier purveyor of cannabis education to customers at dispensaries across the United States and we are excited to strategically partner with them and introduce an innovative co-branded concept to a Canadian market craving evidence-based information on cannabis and its potential health benefits," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "Partnering with Seed allows us to offer a wider range of cannabis education products and services through our Cannvas Kiosk initiative to better serve our partners and deliver accessible and unbiased cannabis learning resources to as many Canadians as possible."

Developed by Horizon Display - leading interactive experts providing and enhancing digital solutions for top brands such as Intel, Tesla, Nike, Disney and more for over 10 years - Seed was created to provide dispensaries with an advanced tool to improve customer experience, support staff and move product. Collaborating with a team of interactive education experts, scientists and cannabis industry specialists, Seed compiles accurate and timely information about cannabis and related products and transforms its research into one of the most advanced interactive education platforms in use at American dispensaries today.

The partnership allows for minimal capital requirements from Cannvas, as the Company gains access to Seed's existing facilities and services, including its comprehensive in-house system for the manufacturing, distribution and content creation of its kiosks. Plans are in the works to integrate Cannvas - and now Seed - learning kiosks with select health clinics and platforms from coast to coast whereby users engaging with the kiosk have an opportunity to follow up with a licensed medical practitioner, should they so choose, and these clinics or platforms will be among their options. Cannvas and Seed will also collaborate on integrating Cannvas.Me technology and content into Seed kiosks to further improve accessibility to free, unbiased and physician-backed education about the potential health benefits of medical and adult-use cannabis.

"This is a wonderful opportunity for all Canadians curious about cannabis consumption but unsure where to turn for reliable, accurate and timely education on its potential health benefits," said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. "Bringing the Seed kiosk brand to Canada increases our chances of reaching active and potential cannabis consumers where they shop, eat, work and live through on-site learning resources like the Cannvas.Me platform and equipping them with the information they need to make informed decisions on cannabis usage prior to speaking to their health care provider."

About Seed
Seed is developed by Horizon Display—leading interactive experts who have been providing digital solutions for top brands and enhancing retail environments and experiences for over 10 years. Seed was developed to provide dispensaries with an advanced tool to enhance the buying experience for their customers, support their staff, and sell more product. To create Seed, its team of researchers logged thousands of hours across several states speaking to scientists and industry specialists to compile the most up-to-date information about cannabis and related products. Its engineers, interactive education experts and designers then took that content to create one of the most advanced interactive education platforms available in dispensaries today. For more information, please visit getseed.io.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

[PotterBanker]

Cannvas Secures Exclusive Cannabis Education and Analytics Partnership with US Cannabis Pharmaceutical

https://www.newswire.ca/news-releases/cannvas-secures-exclusive-cannabis-education-and-analytics-partnership-with-us-cannabis-pharmaceutical-800113473.html

USA Cannabis Market Projected To Reach Over $23B by 2022

TORONTO, April 10, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to establish a working partnership with US Cannabis Pharmaceutical Research and Development ("US Cannabis"), a resource for organizations seeking to normalize, legalize and develop medicinal cannabis. The deal positions Cannvas as an exclusive, leading provider of cannabis education and analytics to US Cannabis and its vast network of clients.

"As the global cannabis industry grows and the need for an arm's length third-party organization to provide unbiased education and information around all aspects of cannabis becomes more apparent, we're proud to partner with US Cannabis as their leading source of trusted cannabis-related learning," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "This deal is structured to further our growth plans for 2019 while significantly expanding the reach of our educational and analytics platforms into the United States, a projected $23.4 billion market for recreational cannabis by 2022 and $8 billion for medicinal by 2024 according to BDS Analytics."

A key partnership for both organizations, Cannvas and US Cannabis will work together to deliver cannabis education to potential and active cannabis consumers through the Cannvas.Me digital learning resource. Cannvas will reinforce US Cannabis' goal of normalizing and developing medicinal and therapeutic cannabis through US Cannabis' vast partner network across the United States. Both companies believe educating the public about the investment, business and job opportunities around cannabis legalization will complement strengthened education on the plant's potential health benefits, and the Cannvas.Me platform is well-positioned to meet that challenge.

"Over the next 5 years, the global cannabis industry will grow faster than any other industry in the world," says Michael Patterson, CEO of US Cannabis. "Accurate data analytics and education from a trusted source are critical to the development of global standards of this new legal industry. Cannvas provides the best platform to use with our clients in the United States and abroad to facilitate consistent training, increased compliance with local, state, and federal laws, and create awareness of the consumer base locally and globally. We are proud to work with Cannvas to develop the gold standard for cannabis operations and compliance."

US Cannabis provides services to help an array of clients - from startups to seasoned investors, established operations to Native American tribes and government agencies. Cannvas will support these efforts through the licensing of educational software, the use of cannabis data and analytics to better understand key industry trends and drivers for the businesses with whom US Cannabis works closely, placement of Cannvas educational kiosks in existing US-based dispensaries and clinics, and other elements designed to elevate the level of learning Americans experience around cannabis. With more than a dozen states expected to pass new cannabis laws by 2025, according to New Frontier Data, the projected growth of the American cannabis market will provide many more opportunities for US Cannabis and Cannvas to work together as this partnership evolves.

About US Cannabis Pharmaceuticals

US Cannabis serves as a resource for organizations seeking to normalize, legalize and develop medicinal cannabis by engaging in commerce, marketing, regulatory reform and product/process development. Its mission is to move society forward through legalized cannabis. It believes the most powerful form of advocacy is commerce and the best way to promote cannabis is by working together to create a robust industry. US Cannabis seeks to achieve these objectives by helping clients ensure they meet licensing requirements, comply with regulations and effectively manage their operations to ensure success for all stakeholders. For more information, please visit www.uscprd.com.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading digital cannabis education and analytics company providing accessible and evidence-based education while harnessing the power of cannabis data and analytics to deliver deeper insights into consumer behaviour and paint a clearer picture of cannabis consumption across Canada.

[PotterBanker]

Cannvas Acquisitions Subsidiary Exploring Growth Opportunities Across United States

https://www.newswire.ca/news-releases/cannvas-acquisitions-subsidiary-exploring-growth-opportunities-across-united-states-899792451.html

Focus on Emerging Multi-Billion Dollar California Market

TORONTO, April 9, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce Cannvas Cannabis Acquisitions Corp. ("Cannvas Cannabis"), a wholly-owned subsidiary with a focus on investment and acquisition in the expanding global cannabis sector, has been actively exploring opportunities with data-driven organizations across the United States to expand its dataset of cannabis consumer trends through strategic partnership and merger and acquisition opportunities, with a significant focus on the US $2.5 billion California cannabis market.

"As America remains on the verge of exploding into the leading global cannabis marketplace, it is in the best interests of our organization and stakeholders to investigate all relevant growth opportunities for Cannvas and seek out strategic partners with whom we can grow all aspects of our company and contribute to the promotion of responsible and knowledge-based cannabis use," said Steve Loutskou, Chief Executive Officer, Cannvas Cannabis Acquisitions. "We are doing our due diligence in exploring a number of options to potentially expand the Cannvas brand into the United States, particularly California which represents nearly a third of the North American market and currently encompasses more than a million medical cannabis consumers."

With a population of nearly 40 million, approximately 10% of whom are legal medical cannabis users, California is considered to be among the largest recreational and medical cannabis markets in the world, alongside Canada. In the late 1990s, it was the first U.S. state to legalize medical cannabis and recreational cannabis sales became legal in January 2018. That year, California retail stores reportedly sold US $2.5 billion of cannabis, compared to $1.5 billion or lower in Colorado, Washington and Oregon. The golden state is projected to account for nearly $25 billion of cannabis sales by 2026.

Reports indicate more than 30% of all cannabis sales in California in 2018 were vapes, demonstrating the growing trend of more sophisticated and discerning audiences looking to learn more about alternative and healthier methods of ingestion. Cannvas hopes to leverage its educational and data analytics properties and work with retailers to offer consumers more robust education around the potential health benefits of cannabis, increase incremental sales through accessible product knowledge and better target potential and active users through in-depth analytics.

While Cannvas is actively seeking growth opportunities with American cannabis data organizations, the Company is also exploring options with U.S. entities on the distribution and fulfillment sides of the cannabis industry. The United States will likely one day represent the world's largest cannabis market, with 65 percent of its population already residing in states where cannabis is either medically and/or recreationally legal. According to BDS Analytics, the U.S. legal cannabis market is projected to reach US $20.9 billion by 2021.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

About Cannvas Cannabis Acquisitions
Cannvas Cannabis Acquisitions is a wholly-owned subsidiary of Cannvas MedTech with a focus on investment and acquisition in the expanding global cannabis sector. It seeks to complement the current product and services line offered by Cannvas through strategic investments and acquisitions, continuing development and discovery of emerging trends and patterns in the cannabis sector.

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-appoints-wesley-tulshi-director-of-hololens-hw-group-at-microsoft-to-ai-technology-and-data-advisory-board-851833074.html

[greenwillow]

Impressive.

[PotterBanker]

Cannvas.Me experiences record 524% increase in user engagement and on track for 50 million article views and 4 million unique visitors

https://www.newswire.ca/news-releases/cannvas-me-experiences-record-524-increase-in-user-engagement-and-on-track-for-50-million-article-views-and-4-million-unique-visitors-843524489.html

Platform user base now spans over 80 countries and 1,100 cities around the world

TORONTO, March 26, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce unprecedented growth of its Cannvas.Me (www.cannvas.me) digital cannabis education platform as more global users from over 80 countries and 1,100 cities turn to Cannvas.Me for credible and evidence-based cannabis education. With user growth exceeding expectations and the platform's global reach expanding at a rapid pace, Cannvas.Me is poised to become the household name for cannabis education all while increasing its unique dataset to paint a clearer picture of cannabis consumption across Canada.

"We are thrilled with our consistent new user acquisition and the way in which we keep existing users interested and engaged with Cannvas.Me, adding targeted new sections based on user needs including Cannvas For Her, Physician's Corner, our upcoming Athlete's Corner and much much more," said Shawn Moniz, Chief Executive Officer. "With so many visitors to Cannvas.Me in such a short period of time, it's clear not only Canadians, but the global audience of the 80 countries using our platform are starved for more in-depth evidence-based education on cannabis and understand that Cannvas has evolved into a trusted resource for physician-backed information on all aspects of the plant."

Since the launch of Cannvas.Me in October, the educational platform has experienced a consistent month-to-month user growth of 30%, with a meteoric rise of 524% in March. The site is now on track to have over 4 million unique users accessing its free and unbiased cannabis education in 2019, with over 50 million views of Cannvas articles and courses before year's end.

This puts Cannvas on track to have over 90% of countries around the world engaging with its content before the end of 2019.

The average session duration for Cannvas.Me users has also increased month-to-month since the site's launch, up 10% each month in the past six months. With users spending an average of nearly 10 minutes on the site per visit."Through a network of strategic partnerships focused on content and data sharing, coupled with a groundswell of global users looking to learn more about cannabis, Cannvas continues to outpace expectations as it surpasses growth projections," said Steve Loutskou, Chief Operating Officer, Global Markets. "We are thrilled with these results and expect our media and advertising partners to feel the same as their products and services are reaching more relevant audiences as our revenue streams continue to grow alongside our user base."

The Company announced that it has issued a total of 38,000 common shares at a deemed price of $0.265 per common share to a service provider pursuant to a consulting agreement entered into with the service provider.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-appoints-expert-in-seniors-issues-aislin-o-hara-to-medical-advisory-board-899277432.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-appoints-dinesh-kandanchatha-to-lead-ai-technology-and-data-advisory-board-837372813.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-and-ellementa-u-s-based-cannabis-health-and-wellness-network-for-women-partner-to-explore-data-about-key-consumers-893471423.html

[PotterBanker]

https://www.newswire.ca/news-releases/cannvas-appoints-leading-u-s-based-cannabis-educator-to-advisory-board-844708444.html

[PotterBanker]

Cannvas Exhibits Cannabis Data AI Technologies at Cantech Conference

https://www.newswire.ca/news-releases/cannvas-exhibits-cannabis-data-ai-technologies-at-cantech-conference-824110305.html

Speaking Engagements to Demonstrate Importance of Big Data and Analytics

TORONTO, Jan. 29, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis educator and data company, is pleased to announce it will have a substantial presence at the 2019 Cantech Investment Conference, taking place January 29-30 at the Metro Toronto Convention Centre in the heart of the city's downtown core.

"We are thrilled to be exhibiting our Cannabis Data AI technology and being part of the Cannabis and Big Data Panel. We have a significant presence at this year's Cantech Investment Conference, and with it the opportunity to signal to investors how our Cannabis Data AI is at the cusp of driving substantial growth in the industry as a major catalyst for licensed producers and dispensaries here in Canada" said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc.

Cannvas MedTech will be at booth 622 at this year's Cantech conference, with speaking engagements scheduled on each day of the conference. On Tuesday, January 29, CEO Shawn Moniz will participate in a discussion panel on the subject of Cannabis and Big Data, moderated by a member of Toronto law firm Fogler Rubinoff LLP. On Wednesday, January 30, Shawn will take to the Paradigm Stage for a featured speaking appearance expected to stress the importance of cannabis analytics in a nascent industry, positioning Cannvas as a leading source of comprehensive and unbiased information on the behaviours of active and potential cannabis consumers across Canada.

While at the conference, the senior management team at Cannvas expects to meet and connect with hundreds of leading Canadian technology companies, schedule private meetings with business leaders and influencers, and learn more about potential partnership opportunities with like-minded organizations.

The Cantech Investment Conference is put on by Cambridge House International, producing North America's largest resource conferences and Canada's largest technology investment conference. For 25 years, Cambridge House has produced flagship must-attend events and provided industries with platforms for networking, education and investment discovery. Cantech is a hallmark event attracting investors and media from across North America to meet with Canadian innovation entrepreneurs.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

[PotterBanker]

darn greys. Hopefully they will be getting a real ticker soon.

[greenwillow]

Nice addition. I'd consider a few of these, but they're grey right now.

[PotterBanker]

Cannvas Appoints First Member of Newly-Formed Cannabis Sciences Advisory Board

https://www.newswire.ca/news-releases/cannvas-appoints-first-member-of-newly-formed-cannabis-sciences-advisory-board-801835584.html

Angela Smith, PhD To Provide Independent Scientific Consultation, Oversight and Original Content for Cannvas.Me Education Platform

TORONTO, Jan. 28, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis educator and business technology company, is pleased to announce the first appointee to its newly-formed Cannabis Sciences Advisory Board, providing independent scientific oversight and original content for the Cannvas.Me cannabis education platform. Angela Smith, PhD, joins Cannvas as the Board lead, bringing with her a wealth of experience in medical, scientific and clinical affairs for Canadian medicinal and recreational cannabis brands and natural health products, and leading international food brands.

"We are thrilled to welcome Angela to the Cannvas team as the first member of our Cannabis Sciences Advisory Board, where she will be instrumental in guiding our educational content to better disseminate timely evidence-based scientific research around cannabis and its myriad uses," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Cannvas continues to lead the way in accessible and physician-backed, educator-approved cannabis education, and Angela's appointment strengthens our commitment to go above and beyond basic Cannabis 101 and provide users with credible knowledge and justification around the latest studies on cannabis and their impact on the health and wellness of Canadians."

The Cannabis Sciences Advisory Board is an independent panel of esteemed and established scientific consultants from across a range of industries providing oversight and original content to the Cannvas.Me digital cannabis education platform. As the first appointee, Angela will lead the Board's activities in determining in which areas of current cannabis scientific research to focus its efforts while leveraging her past experience coordinating and managing medical expert advisory boards to develop the structure of the Board's contributions, activities and inquiries.

A PhD-level scientist with over a decade of experience in basic and clinical research and teaching, and expert knowledge in regulatory, medical, scientific, and technical affairs, Angela is the founder of Catalyst Life Sciences Consulting, a boutique firm providing a wide range of medical, scientific and regulatory consulting services for Canadian natural health products, highly regulated food products including infant formulas and foods, and medical and recreational cannabis. She brings with her a strong working knowledge of North American and international regulatory frameworks, including the Federal Cannabis Act and Provincial/Territorial cannabis regulatory frameworks.

Angela spent 10 years in the food and natural health products industry, leading and supporting prenatal, maternal and infant scientific affairs. Her expertise included the preparation of evidence-based regulatory documentation and scientific evidence, coordination, development and evaluation of educational program initiatives for healthcare professionals and consumers, and providing scientific expertise and evidence-based guidance to senior executives.

Angela has worked on projects with the University of Toronto, Toronto's Hospital for Sick Children and B.C. Women's and Children's Hospital, among others. Angela has amassed a great deal of experience developing and managing medical and continuing education programs for healthcare professionals through organizations including the College of Family Physicians of Canada, the Royal College of Physicians and Surgeons of Canada and the Canadian Council on Continuing Education in Pharmacy. Over her career she has also made valuable contributions to stakeholder consultations on health policies and position statements with the federal government, expert groups and associations.

Operating independent of any licenced producers or clinics, Cannvas.Me works with its Medical Advisory Board and Educational Advisory Panel and newly-formed Cannabis Sciences Advisory Board to provide a safe space for cannabis education with no pressure to purchase or consume.

The Cannabis Sciences Advisory Board will consist of prominent Canadians and Americans who are among the leaders in their fields with robust backgrounds in education, health sciences, medicine and research. Members of the Board will be in constant communication with the Cannvas.Me team to offer guidance on new educational modules, oversight of and contributions to original Cannvas.Me content, and insights into health sciences, clinical trials, medical, scientific and regulatory affairs, and other related topics.

Additionally, the company issued a total of 487,500 common shares (the "Shares") at a deemed value of $0.30 per share to certain persons and a related party for fees owed totaling approximately $146,250.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

For additional information:
CannvasMedTech.com

[greenwillow]

New board. Is Canvf a newly public company now?

Interesting.

[PotterBanker]

Cannvas Signs Deal with NexTech for Augmented Reality Solutions for Cannvas Kiosk Rollout

https://www.newswire.ca/news-releases/cannvas-signs-deal-with-nextech-for-augmented-reality-solutions-for-cannvas-kiosk-rollout-806853410.html

AR To Support Delivery of Free and Physician-Backed Digital Cannabis Education

TORONTO, Jan. 22, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis educator and business technology company, is pleased to announce it has agreed to a deal with NexTech AR Solutions Corp.(CSE: NTAR) (OTC: NEXCF), whose mission is to bring augmented reality (AR) to the masses through its web-enabled AR e-commerce, AR e-learning and AR live streaming platforms to create the first AR ecosystem, to collaborate on enhancing the user experience of its digital cannabis education kiosks across Canada.

"Working with NexTech allows Cannvas the opportunity to create a first-to-market AR-based cannabis learning program and lead the way for the digital evolution of education as it continues to intertwine with technology to generate new and exciting ways for people to take in information," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "It has been proven that companies who personalize the user experience through AR enjoy an improvement in their customer relations and overall profitability, and our goal through this partnership with NexTech is to take our Cannvas Kiosk to the next level and ensure users receive accurate and evidence-based cannabis information customized to their needs and location."

NexTech brings AR to a wide audience through its own AR ecosystem, featuring e-commerce solutions for websites, AR learning and education and AR live streaming for events. Its AR web-enabled e-commerce platform is currently integrated with Shopify, WordPress and Magento, and its e-learning platform "edCetra" has been used by Fortune 500 companies such as Imperial Oil, Bombardier and Staples, as well as the Library of Congress and others to educate and train employees.

Through its partnership with NexTech, Cannvas expects to refine the user experience of its Cannvas Kiosks, a network of learning kiosks in high-traffic retail areas across Canada to improve accessibility to free and physician-backed education about the potential benefits of medical and adult-use cannabis. Cannvas hopes to use AR to build on the current Kiosk platform, attracting a wider audience and extending the length of each consumer interaction while delivering a more memorable and lasting educational impression.

"As a leading digital cannabis education and business technology company, we are always exploring ways to leverage new technologies in support of the educational content we provide around the potential health benefits of cannabis," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "The rise of AR as a prevalent marketing tool coupled with the proven track record of NexTech working with top brands to deliver personalized AR experiences to their customers made it an easy decision to retain their services and strengthen the impression our Cannvas Kiosk leaves on cannabis-curious users from coast to coast."

Content at each Cannvas Kiosk will be powered by the Cannvas.Me platform. Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about health care through cannabis. Its mission is to place users in the driver's seat of their health care journey, arming them with unbiased information on whether medicinal or therapeutic use of cannabis can be beneficial to their lifestyle.

Plans are in the works to integrate Cannvas learning kiosks with select health clinics and platforms from coast to coast whereby users engaging with the Kiosk have an opportunity to follow up with a licensed medical practitioner, should they so choose, and these clinics or platforms will be among their options.

Cannvas and NexTech plan to collaborate on data collection and analysis to examine consumer behaviour patterns at Cannvas Kiosks and leverage that information to ensure optimal user experiences. Both companies will also explore their existing networks and strategic partnerships to assess whether there is potential to form a joint service offering through the Cannvas Kiosk platform or an otherwise undiscovered opportunity.

About NexTech AR Solutions Corp.
NexTech is bringing augmented reality (AR) to the masses by creating an AR ecosystem featuring eCommerce solutions for websites, AR learning and education as well as AR live streaming for events. The company has filed a patent around its AR web-enabled eCommerce platform which has been integrated with Shopify, WordPress and Magento. The AR can "go live" on any ecomm site with just a few lines of embed code creating a highly scalable platform. The global eCommerce industry is a $2.8 trillion-dollar marketplace and growing. NexTech has acquired its e-learning platform "edCetra" which has been used by Fortune 500 companies such as Imperial Oil, Bombardier and Staples, as well as the Library of Congress and others to educate and train employees. NexTech has added augmented reality ("AR") training and education options into the platform and expects to launch in 2019. The company is also working on bringing forth its AR live streaming platform for shows and live events. All of the company's platforms run off of one CRM which allows for its AR ecosystem to rise up. NexTech launched its ARitize™ app in August 2018, which is capable of hosting many brands 3D objects and augmented reality experiences. NexTech also owns a large and diverse revenue generating App Portfolio that is deployed on the iTunes and Google play store which it intends to ARitize™. For more information please visit nextechar.com.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

For additional information:
CannvasMedTech.com